Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Thorax. 2022 Jan 10;77(7):663–668. doi: 10.1136/thoraxjnl-2021-217041

Table 1.

Demographic characteristics of participants and those who reported wheeze, bronchitic symptoms, shortness of breath or secondhand nicotine vape exposure during the study period*

Total
Wheeze
Bronchitic symptoms
Shortness of breath
Secondhand nicotine vape exposure
N=2090 N=510 N=811 N=480 N=542

Race
 Asian 72 (3.4) 16 (3.1) 27 (3.3) 19 (4.0) 17 (3.1)
 Black 31 (1.5) 9 (1.8) 12 (1.5) 2 (0.4) 6 (1.1)
 Hispanic white 1081 (51.8) 214 (42.0) 378 (46.7) 254 (53.0) 241 (44.5)
 Non-hispanic white 732 (35.1) 222 (43.5) 320 (39.5) 168 (35.1) 237 (43.7)
 Others 172 (8.2) 49 (9.6) 73 (9.0) 36 (7.5) 41 (7.6)
Parental education at baseline
 Completed grade 12 or less 574 (27.5) 113 (22.2) 185 (22.8) 142 (29.6) 128 (23.6)
 Some college 648 (31.0) 164 (32.2) 268 (33.0) 154 (32.1) 208 (38.4)
 Completed college or more 622 (29.8) 183 (35.9) 279 (34.4) 136 (28.3) 153 (28.2)
 Missing 246 (1 1.8) 50 (9.8) 79 (9.7) 48 (10.0) 53 (9.8)
Sex
 Female 1036 (49.6) 258 (50.6) 419 (51.7) 337 (70.2) 264 (48.7)
 Male 1054 (50.4) 252 (49.4) 392 (48.3) 143 (29.8) 278 (51.3)
*

χ2 tests were performed comparing the demographic characteristics of participants with wheeze, bronchitic symptoms, shortness of breath, secondhand nicotine vape exposure to participants without the specific respiratory outcome or secondhand nicotine vape. N (%) is shown in the table. Significant differences (p<0.05) are shown in bold.

Total number of participants reporting wheeze, bronchitic symptoms, shortness of breath or secondhand nicotine vape exposure, at least once, over the study period (waves 1–4).